Sector
PharmaceuticalsOpen
₹186Prev. Close
₹184.8Turnover(Lac.)
₹311.4Day's High
₹188Day's Low
₹184.2752 Week's High
₹369.752 Week's Low
₹155Book Value
₹91.91Face Value
₹10Mkt Cap (₹ Cr.)
895.6P/E
33.41EPS
5.56Divi. Yield
1.61Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 48.21 | 48.21 | 48.21 | 43.25 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 368.66 | 347.38 | 330.51 | 203.6 |
Net Worth | 416.87 | 395.59 | 378.72 | 246.85 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 204.52 | 222.83 | 179.29 | 153.69 |
yoy growth (%) | -8.21 | 24.28 | 16.65 | -15.33 |
Raw materials | -127.82 | -137.74 | -101.16 | -91.24 |
As % of sales | 62.5 | 61.81 | 56.42 | 59.36 |
Employee costs | -21.05 | -18.33 | -20.02 | -18.33 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 16.16 | 32.7 | 15.73 | 6.96 |
Depreciation | -4.32 | -4.1 | -3.47 | -3.22 |
Tax paid | -4.42 | -9.23 | -4.51 | -2.25 |
Working capital | 53.98 | -10.52 | 14.2 | -0.58 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -8.21 | 24.28 | 16.65 | -15.33 |
Op profit growth | -48.96 | 30.3 | 158.76 | -48.38 |
EBIT growth | -47.64 | 68.3 | 59.58 | -41.25 |
Net profit growth | -49.96 | 109.2 | 138.37 | -44.65 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 629.6 | 614.59 | 550.99 | 477.52 | 491.81 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 629.6 | 614.59 | 550.99 | 477.52 | 491.81 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 3.98 | 14.61 | 3.07 | 10.6 | 17.99 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Vice Chairman
Surendra Somani
Company Sec. & Compli. Officer
Sunil Sodhani
Independent Director
Siddhan Subramanian
Independent Director
Sunita Banerji
Independent Director
Mamta Biyani
Independent Director
Narayan Atal
Chairman (Non-Executive)
Susheel Somani
Non Executive Director
Adarsh Somani
Non Executive Director
Varun Somani
Parijat House 1076,
Dr E Moses Road Worli,
Maharashtra - 400018
Tel: 91-22-43661111
Website: http://www.kopran.com
Email: sunil@kopran.com
Office No 56-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
Kopran Ltd., incorporated on April 26, 1958, was promoted by the Somani group and is controlled by Parijat Enterprises. The company came out with a public issue at a premium, in Nov.92, to finance its...
Read More
Reports by Kopran Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.